We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

CellCentric and ZoBio Enter into Partnership

Both Companies are working together to develop lead compounds against epigenetic drug targets.
News

AMRI Further Expands Discovery Capabilities in India

Two strategic hires bring additional flexibility to global drug discovery operations.
News

e-Therapeutics’ ETS2101 Enters Phase I Clinical Trial in Brain Cancer

First findings are expected in late 2012.
News

Codexis Selected for Third Presidential Green Chemistry Award in Seven Years

The award, from the U.S. Environmental Protection Agency, is for the development of an efficient biocatalytic process to manufacture simvastatin, a leading drug for treating high cholesterol.
News

Industrial Biotechnology Companies Receive Green Chemistry Awards

The Biotechnology Industry Organization (BIO) congratulated member companies Elevance Renewable Sciences and Codexis on receiving 2012 Presidential Green Chemistry Challenge Awards.
News

Polyphor and Boehringer Ingelheim Sign Collaboration

The collaboration will see Polyphor apply its proprietary MacroFinder® drug discovery technology to identify and optimize novel macrocyclic drug candidates selected by Boehringer Ingelheim.
News

Caltech Chemical Engineers Devise New Way to Split Water

This nontoxic, noncorrosive, "low-temperature" method makes use of wasted heat.
News

D3 Pharma and Encap Drug Delivery Continue Partnership

D3 Pharma continue partnership to accelerate the commercial manufacturing and product licensing programme for Plenachol™.
News

Pharmanest Initiates Phase II Study of SHACT

Goal of the study is to evaluate the effect of SHACT in connection with IUD insertion in women.
News

Cobra Biologics and Alligator Bioscience AB Sign Monoclonal Antibody Manufacturing Agreement

Agreement for the production of monoclonal antibody drug substance and drug product for pre-clinical studies and Phase I-II clinical trials.
Advertisement